SAIL Fusion earned FDA clearance for its BowTie sacroiliac joint fusion system, the devicemaker said April 23. 

Centinel Spine saw worldwide disc replacement revenue of $20.9 million in the first quarter of 2024.

Kevin Lobo and Joaquin Duato are among the highest-paid CEOs of orthopedic medtech companies.

Here are 10 developments in the world of spinal technology: 

Phoenix-based Barrow Neurological Institute was chosen as the inaugural site for the Neuralink PRIME Study.

From leadership moves to FDA nods, here are six updates from spine and orthopedic medtech companies since April 10.

Medtronic CEO Geoffrey Martha's most recent annual compensation was $15.4 million, according to the company's Securities and Exchange Commission proxy statement for fiscal 2023.

Centinel Spine reached more than 5,000 cases with the Prodisc C Vivo and Prodisc C SK implants, the company said April 16.

Orthofix named Andres Cedron as its chief legal officer, the devicemaker said April 16. 

Xstim earned FDA premarket application approval for its spine fusion stimulator, the company said April 16.

RSB Spine is suing Salt Lake City-based devicemaker Innovasis over a patent for the InterPlate device.

From product launches to a business acquisition, here are six updates from spine and orthopedic devicemakers since April 3.

DePuy Synthes is launching its TriALTIS pedicle screw system, the devicemaker said April 9.

Many areas of the global spine device market are expected to grow in the coming years, researchers are anticipating.

Proprio partnered with the Biedermann Group to integrate spinal implants into the Paradigm artificial intelligence system.

Here are four key updates from spine and orthopedic medtech companies since March 27.

Spine devicemaker Accelus named two new people to its leadership team — Rob German as vice president of research and development and Luke Perkins as senior director of product management.

Captiva Spine launched its TransFasten-LSF sacroiliac joint fusion system for minimally invasive procedures.

ZimVie, Zimmer Biomet's spine and dental spinoff, has officially made its exit from the spine market after a tumultuous year, selling the business to global investment firm H.I.G. Capital. 

Stryker CEO Kevin Lobo's total compensation grew from $18.6 million in 2022 to about $20.8 million in 2023, according to a recent Securities and Exchange Commission proxy filing.